Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004983
Filing Date
2025-07-14
Accepted
2025-07-14 16:01:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3314
  Complete submission text file 0001950047-25-004983.txt   4821
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Subject) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-19731 | Film No.: 251121740
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PROVENTION BIO, INC. P.O. BOX 666 OLDWICK NJ 08858
Business Address
Bluestone Jeffrey (Reporting) CIK: 0001771814 (see all company filings)

Type: 144